Stromal tumor-associated eosinophils predict therapeutic resistance and survival in locally advanced tongue squamous cell carcinoma after neoadjuvant therapy
S-TATE serves as an independent prognostic indicator in patients with locally advanced TSCC receiving neoadjuvant therapy. Quantifying S-TATE in post-treatment specimens may help tailor adjuvant therapy intensity and refine surveillance strategies. Patients with elevated S-TATE levels should receive closer follow-up.
Authors
- Wanming Hu
- Jiaming Huang (ORCID: https://orcid.org/0009-0008-4993-760X)
- Lei Yuan
- Xinyi Xian
- Xiujiao Shen
- Wenjian Qin
- Yanfeng Chen
- Jing Zeng
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Sciences (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1177/17588359261424663
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00